Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin's Lymphoma (HL): Data from UKLG LY09 (ISRCTN97144519)

LY09 Trial Management Group

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageUndefined
Pages (from-to)68-69
Number of pages2
JournalHaematologica
Volume92
Issue numberSupplement 5
DOIs
Publication statusPublished - Nov 2007
Event7th International Symposium on Hodgkin Lymphoma - Cologne, Germany
Duration: 3 Nov 20077 Nov 2007

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Cite this